SCHEMBL8974138

SCHEMBL8974138

NS(=O)(=O)c1ccc(C2=CC(C(F)(F)F)(C(F)(F)F)C=C2c2ccc(C(F)(F)F)nc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.45
PTGS2 P35354 11/20 0.43
PTGS1 P23219 9/20 0.43
KCNH2 Q12809 3/20 0.41
MAP4K4 O95819 1/20 0.41
PIK3CA P42336 1/20 0.41
MINK1 Q8N4C8 1/20 0.41
PI4KB Q9UBF8 1/20 0.41
CA12 O43570 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
PDPK1 O15530 2/20 0.39
CYP2C9 P11712 1/20 0.38
VRK2 Q86Y07 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974555 0.88 KIF11 (0.41) KIF11PTGS2PTGS1CA12CA2
SCHEMBL8974393 0.88 KIF11 (0.46) KIF11PTGS2PTGS1KCNH2MAP4K4
SCHEMBL8974291 0.86 KCNH2 (0.53) KIF11PTGS2PTGS1KCNH2MAP4K4
SCHEMBL8973824 0.86 PTGS2 (0.46) KIF11PTGS2PTGS1KCNH2MAP4K4
SCHEMBL9115734 0.85 PTGS2 (0.47) KIF11PTGS2PTGS1KCNH2MAP4K4
SCHEMBL8974133 0.84 KIF11 (0.43) KIF11PTGS2PTGS1KCNH2MAP4K4
SCHEMBL9117164 0.83 PTGS2 (0.42) KIF11PTGS2PTGS1KCNH2MAP4K4
SCHEMBL8974214 0.83 KCNH2 (0.44) KIF11PTGS2PTGS1KCNH2MAP4K4
SCHEMBL9116807 0.83 PTGS2 (0.42) KIF11PTGS2PTGS1KCNH2MAP4K4
SCHEMBL8974140 0.83 KCNH2 (0.44) KIF11PTGS2PTGS1KCNH2MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995030656-A1 SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO claimed
US-5576339-A Pyridyl substituted cyclopentadienes for the treatment of inflamation HUANG HORNG-CHIH (US) 1996-11-19 US disclosed
US-5418254-A Side effect reduction G. D. SEARLE & CO. (US) 1995-05-23 US disclosed